4.5 Article

Neglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo Area

Journal

PLOS NEGLECTED TROPICAL DISEASES
Volume 9, Issue 9, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pntd.0004103

Keywords

-

Ask authors/readers for more resources

Objectives Chagas disease (CD) represents a growing problem in Europe; Italy is one of the most affected countries but there is no national framework for CD and access-to-care is challenging. In 2012 Medecins Sans Frontieres (MSF) started an intervention in Bergamo province, where many people of Latin American origin (PLAO) are resident. A new model-of-care for CD, initiated by Centre for Tropical Diseases of Sacro Cuore Hospital, Negrar (CTD), the NGO OIKOS and the Bolivian community since 2009 in the same area, was endorsed. Hereby, we aim to describe the prevalence of CD and the treatment management outcomes among PLAO screened from 1st June 2012 to 30th June 2013. Methods Retrospective cohort study using routine program data. Screening sessions were done in Bergamo at OIKOS outpatient service and serological confirmation, staging and treatment for CD was offered at the CTD. MSF provided health education on CD, awareness generation prior to screening days, pre-test and post-test counselling through cultural mediators of Latin American origin. Results Of 1305 PLAO screened, 223(17%) had CD. Among 210 patients eligible for treatment, 102 (49%) were lost-to-follow-up before treatment. The median delay from diagnosis to treatment was 4 months (range 0.7-16.6 months). Among 108 started on treatment, 63(58%) completed treatment, 36(33%) interrupted treatment, (33 for drug side-effects, two for patients decision and one due to pregnancy), 6(6%) were lost-to-follow-up and 3(3%) were on treatment at study censuring. Conclusion In this first study focusing on process of care for CD in Italy, less than 30% of patients completed treatment with drop-outs along the cascade of care. There is an urgent need to involve affected communities and local regional health authorities to take part to this model-of-care, adapting it to the local epidemiology. The Italian health authorities should take steps in advocating for a change in the current paradigm.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Isolation and Sequencing of the First Case of Symptomatic MDR Salmonella enterica Subsp. Enterica ST40 in Human in Italy, July 2020

Niccolo Riccardi, Silvia Storato, Arianna Massella, Andrea Ragusa, Marco Prato, Pierantonio Orza, Ilenia Campedelli, Fabio Fracchetti, Chiara Piubelli, Andrea Angheben

Summary: Drug-resistant nontyphoidal Salmonella spp. strains are emerging globally, requiring rapid identification and sequencing for outbreak control. Proactive research and notification are crucial to evaluate transmission routes from livestock to humans and risk management strategies of MDR Salmonella strains.

MICROBIAL DRUG RESISTANCE (2022)

Article Infectious Diseases

Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine

G. Ciusa, F. Guida Marascia, R. Virruso, A. Angheben, G. Guaraldi, A. Cascio

Summary: This case report describes the clinical reactivation of chronic P. malariae infection in a 48-year old Italian man following CoVID-19 vaccination with BNT162b2. The patient presented with fever and splenomegaly, which occurred one month after vaccination. P. malariae was diagnosed using rapid test and Polymerase-Chain Reaction. The transient reduction of immune reactivity post-vaccine is mentioned in literature, but the mechanism remains unknown.

IDCASES (2022)

Review Public, Environmental & Occupational Health

Identifying transferable lessons from cholera epidemic responses by Medecins Sans Frontieres in Mozambique, Malawi and the Democratic Republic of Congo, 2015-2018: a scoping review

Lauren D'Mello-Guyett, Oliver Cumming, Elliot Rogers, Rob D'hondt, Estifanos Mengitsu, Maria Mashako, Rafael Van den Bergh, Placide Okitayemba Welo, Peter Maes, Francesco Checchi

Summary: This review examines the responses to cholera epidemics in three countries and provides recommendations for improving cholera prevention and control efforts. It emphasizes the need for improved epidemic preparedness, strengthened partnerships, and standardized reporting templates.

CONFLICT AND HEALTH (2022)

Review Microbiology

Soil-Transmitted Helminths and Anaemia: A Neglected Association Outside the Tropics

Sara Caldrer, Tamara Ursini, Beatrice Santucci, Leonardo Motta, Andrea Angheben

Summary: This narrative review discusses the association between different helminthic infections and anaemia, emphasizing the importance of recognizing this relationship even in non-endemic countries. The review provides comprehensive information on the epidemiology, lifecycle, clinical spectrum, and diagnostic approach of anaemia, with a particular focus on helminthic infections.

MICROORGANISMS (2022)

Article Medicine, General & Internal

DAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series

Hassaan Zahid, Khawar Aslam, Elin Hoffmann Dahl, Waqas Abbassi, Suleiman Adan, Rafael van den Bergh, Marta A. Balinska, Nasir Hassan Luck

Summary: Globally, there are 58 million people living with HCV infection, with 1.5 million new infections occurring annually. The introduction of DAAs has revolutionized HCV treatment, but the emergence of drug resistance poses a threat to achieving HCV elimination goals. In this study, we discuss 18 patients in a resource-limited setting who failed to respond to both standard and advanced treatment regimens. We emphasize the need for increased attention and research on patients failing treatment and the spread of drug-resistant HCV strains within communities.

OXFORD MEDICAL CASE REPORTS (2022)

Article Public, Environmental & Occupational Health

Prevalence of Chagas disease and strongyloidiasis among HIV-infected Latin American immigrants in Italy - The CHILI study

Paola Rodari, Francesca Tamarozzi, Stefano Tais, Monica Degani, Francesca Perandin, Dora Buonfrate, Emanuele Nicastri, Luciana Lepore, Maria Letizia Giancola, Stefania Carrara, Alessandro Tavelli, Alessandro Cozzi-Lepri, Antonella D'Arminio Monforte, Ronaldo Silva, Andrea Angheben

Summary: This study evaluated the prevalence of Chagas disease and strongyloidiasis infections among HIV-infected migrants from Latin America living in Italy and found that these infections are present in this population. The accuracy of seroassays for Chagas disease and strongyloidiasis in HIV-positive patients is unclear.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2022)

Article Public, Environmental & Occupational Health

Family cluster of Chagas disease among Bolivian immigrants in Italy: High rate of maternal-fetal transmission

Spinello Antinori, Laura Galimberti, Romualdo Grande, Davide Ricaboni, Stefania Sala, Vania Giacomet, Valeria Colombo, Mario Corbellino, Andrea Angheben, Andrea Giacomelli, Anna Lisa Ridolfo

Summary: Chagas disease, caused by Trypanosoma cruzi, affects 6-8 million people worldwide, with cardiac or digestive complications being common. A Bolivian family cluster with seven affected individuals was identified in Milan, Italy, highlighting the challenges of congenital transmission in non-endemic areas. The study emphasizes the need for screening and control of congenital Chagas disease among family members to address the hidden prevalence in non-endemic regions.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2022)

Article Biology

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients

Bronner P. Goncalves, Matthew Hall, Waasila Jassat, Valeria Balan, Srinivas Murthy, Christiana Kartsonaki, Malcolm G. Semple, Amanda Rojek, Joaquin Baruch, Luis Felipe Reyes, Abhishek Dasgupta, Jake Dunning, Barbara Wanjiru Citarella, Mark Pritchard, Alejandro Martin-Quiros, Uluhan Sili, J. Kenneth Baillie, Diptesh Aryal, Yaseen Arabi, Aasiyah Rashan, Andrea Angheben, Janice Caoili, Francois Martin Carrier, Ewen M. Harrison, Joan Gomez-Junyent, Claudia Figueiredo-Mello, James Joshua Douglas, Mohd Basri Mat Nor, Yock Ping Chow, Xin Ci Wong, Silvia Bertagnolio, Soe Soe Thwin, Anca Streinu-Cercel, Leonardo Salazar, Asgar Rishu, Rajavardhan Rangappa, David S. Y. Ong, Madiha Hashmi, Gail Carson, Janet Diaz, Rob Fowler, Moritz U. G. Kraemer, Evert-Jan Wils, Peter Horby, Laura Merson, Piero L. Olliaro

Summary: This study proposes an innovative method to infer the SARS-CoV-2 variants responsible for clinical cases using publicly available population-level data. The analysis of over 100,000 patients from 28 countries suggests that patients hospitalized with Omicron variant infection less often present with commonly reported symptoms compared to patients infected with pre-Omicron variants. Furthermore, patients admitted to hospital after Omicron variant emergence had lower mortality compared to patients admitted during the period when Omicron variant was responsible for only a minority of infections.

ELIFE (2022)

Article Public, Environmental & Occupational Health

Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers

Florian Kurth, Pinkus Tober-Lau, Tilman Lingscheid, Lara Bardtke, Johanna Kim, Andrea Angheben, Federico G. Gobbi, Lena Mbavu, Miriam S. Stegemann, Katrin M. Heim, Frieder Pfaefflin, Nikolai Menner, Mariana Schuermann, Agata Mikolajewska, Martin Witzenrath, Leif E. Sander, Beate Mayer, Thomas Zoller

Summary: In this prospective observational study, it was found that about 37.4% of patients with uncomplicated malaria treated with oral ACT showed post-treatment haemolysis (PTH) on day 14. Patients with PTH had higher initial parasitaemia and a 10-fold decrease in infected red blood cells (oiRBCs) between day 3 and day 14. The occurrence of PTH was more common in African patients, who also showed significantly increased erythropoiesis on day 14.

JOURNAL OF TRAVEL MEDICINE (2023)

Article Medicine, General & Internal

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial

Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis

Summary: The SAVE-MORE trial found that anakinra treatment in COVID-19 pneumonia patients with suPAR levels of 6 ng/mL or more was associated with worse outcomes compared to placebo at day 28. Subgroup analyses showed that anakinra treatment had lower odds of worse outcomes in all studied subgroups. Long-term outcomes at days 60 and 90 also favored anakinra treatment.

ECLINICALMEDICINE (2023)

Review Mycology

Endemic Systemic Mycoses in Italy: A Systematic Review of Literature and a Practical Update

Verena Zerbato, Stefano Di Bella, Riccardo Pol, Francesco D'Aleo, Andrea Angheben, Claudio Farina, Marco Conte, Francesco Luzzaro, Gianluigi Lombardi, AMCLI Mycology Comm, Roberto Luzzati, Luigi Principe

Summary: This study conducted a systematic review on endemic systemic mycoses reported in Italy from 1914 to now, finding 105 cases of histoplasmosis, 15 cases of paracoccidioidomycosis, 10 cases of coccidioidomycosis, 10 cases of blastomycosis, and 3 cases of talaromycosis. Most cases were reported in returning travelers and immigrants, with 32 patients having no history of traveling to an endemic area. Among 46 HIV/AIDS patients, immunosuppression was the major risk factor for contracting these infections and experiencing severe outcomes. The study provides an overview on the microbiological characteristics and clinical management principles of systemic endemic mycoses, focusing on cases reported in Italy.

MYCOPATHOLOGIA (2023)

Review Infectious Diseases

Diagnosis and management of complicated urogenital schistosomiasis: a systematic review of the literature

Tommaso Manciulli, Davide Marangoni, Joaquin Salas-Coronas, Cristina Bocanegra, Joachim Richter, Federico Gobbi, Leonardo Motta, Andrea Minervini, Alessandro Bartoloni, Lorenzo Zammarchi

Summary: Currently, there are no standardized guidelines for the diagnosis or management of the complications of urogenital schistosomiasis (UGS). This systematic review aims to investigate the state of the art in reference to diagnostic approaches and clinical management of this condition.

INFECTION (2023)

Article Microbiology

The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey

Niccolo Riccardi, Roberta Maria Antonello, Andrea Giacomelli, Laura Saderi, Diana Canetti, Carlo Pallotto, Fulvia Mazzaferri, Anna Maria Degli Antoni, Chiara Cardellino, Ilaria Motta, Andrea Calcagno, Marco Falcone, Michele Trezzi, Agnese Comelli, Renato Pascale, Marco Merli, Francesca Binda, Andrea Angheben, Giovanni Sotgiu, Federico Gobbi, Silvia Nozza

Summary: Diagnosis and management of infectious diseases in the emergency department pose challenges, and an online survey of Italian departments of infectious diseases showed shortcomings in the current organization, such as a lack of formal antimicrobial stewardship programs and defined protocols for microbiological tests in the ED.

NEW MICROBIOLOGICA (2022)

Review Infectious Diseases

Pyemotes ventricosus Dermatitis: A Case Report and an Extensive Review of Outbreaks and Clinical Cases

Iacopo Vellere, Alessandro Di Felice, Annarita Botta, Andrea Angheben, Alessandro Bartoloni, Lorenzo Zammarchi

Summary: Pyemotes ventricosus dermatitis is a skin disease caused by free-living mites, which is often underreported and difficult to diagnose. The reduction in pesticide use in agriculture may lead to an increased exposure to Pyemotes spp. in the future.

INFECTIOUS DISEASE REPORTS (2022)

Review Parasitology

Critical analysis of Chagas disease treatment in different countries

Fernanda de Souza Nogueira Sardinha Mendes, Jose Antonio Perez-Molina, Andrea Angheben, Sheba K. Meymandi, Sergio Sosa-Estani, Israel Molina

Summary: This manuscript provides a comparative review of approaches to patients with Chagas disease in the Americas and Europe, highlighting the influence of the socioeconomic context of the host societies.

MEMORIAS DO INSTITUTO OSWALDO CRUZ (2022)

No Data Available